BROADCASTS.com

b'In this episode of The Onco\\u2019Zine Brief Peter Hofland report from the annual meeting of the American Society of Clinical Oncology \\u2013 ASCO \\u2013 which was held May 31st \\u2013 June 4th, 2019.

The American Society of Clinical Oncology is the world\'s leading professional organization for physicians and oncology professionals caring for people with cancer. During the annual meeting Peter Hofland spoke with:

\\u2022 Anna Protopapas, the president and Chief Executive Office of Mersana Therapeutics, a clinical stage biotech company developing antibody-drug conjugates \\u2013 a very specific kind of targeted anti-cancer drug;
\\u2022 Eliran Malki, the Chief executive officer of BELONG.life, the world\\u2019s largest social network for cancer patients and caregivers designed to gain a better understanding of the cancer patient journey, with the goal of optimizing treatment and outcomes;
\\u2022 Dr. Rod Humerickhouse, asset strategy leader oncology at AbbVie, a highly focused research-driven biopharmaceutical company. As a major developer of anticancer drugs, AbbVie\\u2019s oncology scientists understand that outsmarting cancer takes a potent combination of courage, scientific expertise and strategy.

For more information, go to Onco\'Zine at www.oncozine.com'